Ris Orangis, France

Jocelyne Roy


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1995-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Jocelyne Roy

Introduction

Jocelyne Roy, an accomplished inventor based in Ris Orangis, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of two patents, her work primarily focuses on developing compounds with therapeutic benefits.

Latest Patents

Jocelyne's latest patents showcase her expertise in synthesizing complex chemical compounds. Her patents include the innovative "8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors." Additionally, she has developed 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, which contain a unique compound with various substituents that enhance their pharmacological properties. These compounds are particularly useful as hypnotic, anxiolytic, and anticonvulsant agents, addressing significant medical needs in these areas.

Career Highlights

Throughout her career, Jocelyne has worked with renowned companies in the pharmaceutical industry, including Synthelabo and Sanofi-Synthelabo. Her contributions to the field have not only advanced scientific knowledge but also provided new treatment options for various conditions.

Collaborations

Jocelyne has collaborated with several talented professionals, including Pascal George and Mireille Sevrin. Together, they have explored innovative solutions and pushed the boundaries of pharmaceutical research, enhancing the development of new compounds.

Conclusion

Jocelyne Roy stands as a testament to the impact of innovation in the pharmaceutical sector. Her patents and collaborative spirit reflect a commitment to advancing medical science. As she continues her journey, her contributions will likely pave the way for new therapeutic agents that can improve the quality of life for many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…